Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: J AAPOS. 2018 Mar 14;22(2):128–133. doi: 10.1016/j.jaapos.2017.12.005

Table 3.

Treatment-related complications after first ROP treatment by treatment group

Treatment-related complications Laser
(n = 970 eyes)		 Anti-VEGF
(n = 34 eyes)		 Total
(N = 1004 eyes)
Cataract    3 (0.3%)    0 (0.0%)    3 (0.3%)
Hyphema  15 (1.6%)    0 (0.0%)  15 (1.5%)
Glaucoma    1 (0.1%)    0 (0.0%)    1 (0.1%)
Corneal abrasion or ulcer    1 (0.1%)    0 (0.0%)    1 (0.1%)
Corneal opacity    6 (0.6%)    0 (0.0%)    6 (0.6%)
Any above treatment-related complication(s)  25 (2.6%)    0 (0.0%)  25 (2.5%)
95% confidence interval 1.8%–3.8% 0.0%–10.1% 1.7%3.7%